FDA Approves Gilead Cancer Gene Therapy – HuffPost
|
FDA Approves Gilead Cancer Gene Therapy
HuffPost (Reuters) – U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc’s (GILD.O) Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer. |
|
CRISPR Gene Editing Aims to Improve ‘Orphan Crops’
agprofessional.com Nigel and other researchers are working to stay ahead of cassava brown streak using a new technology: Clustered Regularly Interspaced Short Palindromic Repeat, or CRISPR. CRISPR allows geneticists to identify a specific genetic sequence within an … |
Medical News Today |
‘Synthetic gene circuit’ may improve effectiveness of cancer immunotherapy
Medical News Today Researchers from the Massachusetts Institute of Technology (MIT) in Cambridge suggest that their artificial DNA-encoded circuits may help to overcome some of the problems that have dogged the translation of cancer immunotherapy from the laboratory to … Gene circuit switches on inside cancer cells, triggers immune attackMedical Xpress |
|
New gene editing technique for neurons could boost research in brain diseases
FierceBiotech To correct that shortcoming, the Max Planck team combined CRISPR-Cas9 with adeno-associated virus (AAV), a mild viral vector that’s often used for gene delivery. When they delivered the combo to mouse neurons, HDR occurred in an efficient manner, they … |
Medical Xpress |
Gene circuit switches on inside cancer cells, triggers immune attack
Medical Xpress “There has been a lot of clinical data recently suggesting that if you can stimulate the immune system in the right way you can get it to recognize cancer,” says Lu, who is head of the Synthetic Biology Group in MIT’s Research Laboratory of Electronics … |